7/1/2026 Categories: Industries Angelini Industries: total revenues reach €1.7 billion (+4.6%). Growth in pharmaceuticals and industrial technology
1/4/2021 Categories: Pharma Angelini Pharma acquires Arvelle Therapeutics to create a leading European innovator in Central Nervous System (CNS) and Mental Health Disorder treatments
9/9/2020 Luxottica and Fameccanica start the national production of face masks at PalaLuxottica in Agordo
7/8/2020 Piero Tansella joins Angelini Holding to coordinate and develop the Group Business Consumer unit
Angelini Industries